DNA repair and antibody diversification: the 53BP1 paradigm
Trends in Immunology · 2023
DOI: 10.1016/j.it.2023.08.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2023. Verfasst von Eleni Kabrani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Diversification and Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany. E…. Hauptthemen laut MEDLINE: Antibodies, DNA Breaks, Double-Stranded, DNA Repair, Tumor Suppressor p53-Binding Protein 1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MDC, Helmholtz Association.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genome Diversification and Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany. Electronic address: eleni.kabrani@mdc-berlin.de.
- Laboratory of Genome Diversification and Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany; Freie Universität Berlin, Berlin 14195, Germany.
- Laboratory of Genome Diversification and Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany; Charité-Universitätsmedizin Berlin, Berlin 10117, Germany. Electronic a…
Förderung
- MDC
- Helmholtz Association
Zitieren
APA
Kabrani, E., Saha, T., & Di Virgilio, M. (2023). DNA repair and antibody diversification: the 53BP1 paradigm. Trends in Immunology. https://doi.org/10.1016/j.it.2023.08.004
Vancouver
Kabrani E, Saha T, Di Virgilio M. DNA repair and antibody diversification: the 53BP1 paradigm. Trends in Immunology. 2023. doi:10.1016/j.it.2023.08.004
BibTeX
@article{Kabrani2023,
author = {Kabrani, Eleni and Saha, Tannishtha and Di Virgilio, Michela},
title = {DNA repair and antibody diversification: the 53BP1 paradigm},
journal = {Trends in Immunology},
year = {2023},
doi = {10.1016/j.it.2023.08.004}
}
EUVIMED